跳至主要内容
临床试验/ACTRN12612000289819
ACTRN12612000289819已完成3 期

Does Oral Supplementation with Taurine for Patients with Cirrhosis and Muscle Cramps Reduce the Severity and Frequency of Muscle Cramps?

Royal Prince Alfred Hospital0 个研究点目标入组 49 人开始时间: 2012年3月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
49

研究概览

简要总结

Oral supplementation with 2 g taurine/d is safe and results in a clinically significant reduction in the frequency, duration, and intensity of muscle cramps in patients with chronic liver disease. Taurine should be considered as a safe and effective intervention in the management of muscle cramps in individuals with chronic liver disease.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Patients who present to liver clinic with hepatic cirrhosis and who experience muscle cramps more than three times/week
  • Abstinent from alcohol and intravenous drug use for 3 months prior to entry into study
  • If on methadone must be on methadone for 12 months or longer and must be dose stable for 3 months prior to entry into study

排除标准

  • Muscle cramps less than two occasions/week
  • Abnormal levels potassium, magnesium and phosphate
  • Unstable diabetes or a blood sugar level > 15mMol at time of assessment for inclusion in the study
  • Known peripheral neuropathy
  • Known thyroid disease
  • Pulmonary hypertension
  • Known cardiac disease
  • Current or recent (within 3 months of assessment)intravenous drug use
  • Methadone use for less than 12 months
  • Current use of taurine enriched energy drinks

研究者

相似试验